Literature DB >> 33243740

[Cardiac functional alterations and its risk factors in elderly patients with obstructive sleep apnea syndrome free of cardiovascular disease].

Yinghui Gao1, Yongfei Wen1, Xiaoshun Qian2,3, Libo Zhao4,3, Hu Xu4,3, Weihao Xu4,3, Xiaoxuan Kong4,3, Hebin Che5, Yabin Wang3, Lin Liu2,3.   

Abstract

OBJECTIVE: To evaluate the changes of cardiac structure and function and their risk factors in elderly patients with obstructive sleep apnea syndrome (OSA) without cardiovascular complications.
METHODS: Eighty-two elderly OSA patients without cardiovascular disease admitted between January, 2015 and October, 2016 were enrolled in this study. According to their apnea-hypopnea index (AHI, calculated as the average number of episodes of apnoea and hypopnoea per hour of sleep), the patients were divided into mild OSA group (AHI < 15) and moderate to severe OSA group (AHI ≥ 15). The demographic data and the general clinical data were recorded and fasting blood samples were collected from the patients on the next morning following polysomnographic monitoring for blood cell analysis and biochemical examination. Echocardiography was performed within one week after overnight polysomnography, and the cardiac structure, cardiac function and biochemical indexes were compared between the two groups.
RESULTS: Compared with those with mild OSA group, the patients with moderate to severe OSA had significantly higher hematocrit (0.22±0.08 vs 0.17±0.04, P=0.032) and serum creatinine level (70.94± 27.88 vs 54.49±34.22 μmol/L, P=0.022). The left ventricular ejection fraction, interventricular septal thickness, left ventricular posterior wall thickness, left atrial diameter and left ventricular end-diastolic diameter were all similar between the two groups. With a similar early diastolic mitral flow velocity (E) between the two groups, the patients with moderate to severe OSA had a significantly higher late diastolic mitral flow velocity (A) (70.35±6.87 vs 64.09±8.31, P=0.0001) and a significantly lower E/A ratio (0.98±0.06 vs 1.08±0.05, P=0.0001) than the patients with mild OSA. Multiple linear regression showed that the E/A ratio was negatively correlated with AHI (β =- 0.645, P=0.0001).
CONCLUSIONS: Cardiac diastolic function impairment may occur in elderly patients with moderate or severe OSA who do not have hypertension or other cardiovascular diseases, and the severity of the impairment is positively correlated with AHI.

Entities:  

Keywords:  apnea-hypopnea index; cardiac diastolic function; elderly; obstructive sleep apnea

Mesh:

Year:  2020        PMID: 33243740      PMCID: PMC7704368          DOI: 10.12122/j.issn.1673-4254.2020.11.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

1.  Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.

Authors:  Helena Glantz; Magnus C Johansson; Erik Thunström; Cecilia Wallentin Guron; Harun Uzel; Mustafa Saygin; Johan Herlitz; Yüksel Peker
Journal:  Int J Cardiol       Date:  2017-03-25       Impact factor: 4.164

2.  Left ventricular diastolic dysfunction in obstructive sleep apnoea syndrome by an echocardiographic standardized approach: An observational study.

Authors:  Diane Bodez; Sylvie Lang; Catherine Meuleman; Louise Boyer-Châtenet; Xuan-Lan Nguyen; Laurie Soulat-Dufour; Franck Boccara; Bernard Fleury; Ariel Cohen
Journal:  Arch Cardiovasc Dis       Date:  2015-06-08       Impact factor: 2.340

3.  Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort.

Authors:  Gemma Cadby; Nigel McArdle; Tom Briffa; David R Hillman; Laila Simpson; Matthew Knuiman; Joseph Hung
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

4.  Current challenges in the diagnosis and treatment of obstructive sleep apnea syndrome in the elderly.

Authors:  Giannicola Iannella; Antonino Maniaci; Giuseppe Magliulo; Salvatore Cocuzza; Ignazio La Mantia; Giovanni Cammaroto; Antonio Greco; Claudio Vicini
Journal:  Pol Arch Intern Med       Date:  2020-04-06

5.  Obstructive sleep apnoea and right ventricular function: A combined assessment by speckle tracking and three-dimensional echocardiography.

Authors:  Agostino Buonauro; Maurizio Galderisi; Ciro Santoro; Angelo Canora; Maria Luisa Bocchino; Francesco Lo Iudice; Maria Lembo; Roberta Esposito; Sabrina Castaldo; Bruno Trimarco; Alessandro Sanduzzi
Journal:  Int J Cardiol       Date:  2017-05-04       Impact factor: 4.164

6.  Impact of obstructive sleep apnoea on left ventricular mass and global function.

Authors:  D Dursunoglu; N Dursunoglu; H Evrengül; S Ozkurt; O Kuru; M Kiliç; F Fisekci
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

7.  Assessment of subclinical left ventricular dysfunction in obstructive sleep apnea patients with speckle tracking echocardiography.

Authors:  Refik Emre Altekin; Atakan Yanikoglu; Ahmet Oguz Baktir; Mustafa Serkan Karakas; Deniz Ozel; Aykut Cilli; Aytul Belgi Yildirim; Huseyin Yilmaz; Selim Yalcinkaya
Journal:  Int J Cardiovasc Imaging       Date:  2012-02-12       Impact factor: 2.357

8.  Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study.

Authors:  Claudia E Korcarz; Paul E Peppard; Terry B Young; Carrie B Chapman; K Mae Hla; Jodi H Barnet; Erika Hagen; James H Stein
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

9.  Early myocardial functional alterations in patients with obstructive sleep apnea syndrome.

Authors:  Alper Kepez; Elif Yelda Ozgun Niksarlioglu; Tuncay Hazirolan; Ortenca Ranci; Hasan Kutsi Kabul; Ahmet Uğur Demir; Ergün Bariş Kaya; Ugur Kocabas; Kudret Aytemir; Altay Sahin; Lale Tokgozoglu; Nasih Nazli
Journal:  Echocardiography       Date:  2008-11-10       Impact factor: 1.724

Review 10.  Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea.

Authors:  Rita Marinheiro; Leonor Parreira; Pedro Amador; Dinis Mesquita; José Farinha; Marta Fonseca; Tatiana Duarte; Cláudia Lopes; Andreia Fernandes; Rui Caria
Journal:  Curr Cardiol Rev       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.